Novel Palladium(II) and Platinum(II) Complexes with a Fluoropiperazinyl Based Ligand Exhibiting High Cytotoxicity and Anticancer Activity In Vitro

cis-Dichloro-palladium(II) and cis-dichloro-platinum(II) complexes (2, 4) of the general formula [M(N-N)Cl2] (M=Pd(II) and Pt(II), N-N= 1,2-diamino-4-fluoro-5-(4-methyl-1-piperazinyl) benzene, (DFMPB)) and the dicationic palladium(II) complex [Pd(N-N)(CH3CN)2](BF4)2 (3) have been prepared and characterized by elemental analysis, 1H-NMR-, mass spectroscopy, and IR spectroscopy. The cytotoxic effect of these complexes against MDA-231 and MCF-7 human breast cancer cell lines and K562 human leukemia cell line has been studied. The influence was dose dependent and varies with cell type. The palladium(II) complex (2) showed superior cytotoxic effect compared with the corresponding platinum(II) complex and the standard, cisplatin, when tested against all the above cell lines.

[1]  J. A. Walmsley,et al.  Synthesis, characterization and cytotoxicity studies of palladium(II)-proflavine complexes. , 2010, Journal of inorganic biochemistry.

[2]  R. Ian Freshney,et al.  Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications , 2010 .

[3]  Kayed A. Abu Safieh,et al.  New palladium(II) complexes bearing pyrazole-based Schiff base ligands: synthesis, characterization and cytotoxicity. , 2010, European journal of medicinal chemistry.

[4]  Á. Montaña,et al.  The rational design of anticancer platinum complexes: the importance of the structure-activity relationship. , 2009, Current medicinal chemistry.

[5]  M. V. Almeida,et al.  Synthesis and characterization of platinum(II) complexes from trifluoromethyl phenylenediamine, picoline and N-benzyl ethylenediamine derivatives , 2006 .

[6]  Mika Kettunen,et al.  Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin. , 2006, Current medicinal chemistry.

[7]  John A Timbrell,et al.  In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. , 2006, Toxicology letters.

[8]  M. Leskelä,et al.  Iron(II)‐ and Cobalt(II) Complexes with Tridentate Bis(imino)pyridine Nitrogen Ligands Bearing Chiral Bulky Aliphatic and Aromatic Substituents: Crystal Structure of [CoCl2{2, 6‐bis[R‐(+)‐(bornylimino)methyl]pyridine}] , 2005 .

[9]  V. Alverdi,et al.  Characterization studies and cytotoxicity assays of Pt(II) and Pd(II) dithiocarbamate complexes by means of FT-IR, NMR spectroscopy and mass spectrometry. , 2004, Journal of inorganic biochemistry.

[10]  M. Klinga,et al.  Chiral palladium(II) and platinum(II) complexes of diaminocyclohexane: X-ray structures of (1R, 2R)-(-)-1,2-diaminocyclohexane dihydrochloride and its corresponding oxalato platinum(II) complex , 2003 .

[11]  M. Leskelä,et al.  Synthesis, crystal structure and initial biological evaluation of the new enantiomerically pure chiral palladium(II) complex trans-bis[endo-(1R)-1,7,7-trimethylbicyclo[2.2.1]-heptan-2-amino]palladium(II)dichloride. , 2002, European journal of medicinal chemistry.

[12]  K. To,et al.  Potential new antitumor agents from an innovative combination of demethylcantharidin, a modified traditional Chinese medicine, with a platinum moiety. , 2001, Journal of medicinal chemistry.

[13]  Raed A. Al‐Qawasmeh,et al.  Synthesis and properties of some 2,3‐disubstituted 6‐fluoro‐7‐(4‐methyl‐1‐piperazinyl)quinoxalines , 2000 .

[14]  Y. Chen,et al.  Ethylenediamine-palladium(II) complexes with pyridine and its derivatives: synthesis, molecular structure and initial antitumor studies. , 1999, Journal of inorganic biochemistry.

[15]  L. Rashan,et al.  Synthesis and cytotoxic evaluation of the first trans-palladium(II) complex with naturally occurring alkaloid harmine , 1998 .

[16]  R. Fawzi,et al.  Chemical properties and cytotoxic activity of complexes of platinum(II) and palladium(II) containing dmso and various anions; synthesis and structural characterization of [Pt(dmso)2{O2(CO)2CCH2CH2CH2}] , 1998 .

[17]  B. Rieger,et al.  Ultrahigh molecular weight alternating propene/ethene/carbon monoxide terpolymers with elastic properties , 1996 .

[18]  S. Sabri,et al.  Substituted Benzimidazoles. Part 1. Synthesis and Properties of Some 2-Aryl-5-fluoro-6-(4-methyl-1-piperazinyl)-1H-benzimidazoles , 1995 .

[19]  T. S. Srivastava,et al.  Synthesis, spectroscopic, cytotoxic, and DNA binding studies of binuclear 2,2′-bipyridine-platinum(II) and -palladium (II) complexes of meso-α,α′-diaminoadipic and meso-α,α′-diaminosuberic acids , 1992 .

[20]  C. Cocito,et al.  Spectrofluorometry of dyes with DNAs of different base composition and conformation. , 1989, Analytical biochemistry.

[21]  F. Wimmer,et al.  The antitumor activity of some palladium(II) complexes with chelating ligands. , 1989, Anticancer research.

[22]  R. Iemura,et al.  Quantitative structure-activity relationships of H1-antihistaminic benzimidazole derivatives. , 1989, Chemical & pharmaceutical bulletin.

[23]  D. M. Bailey,et al.  Novel amino-substituted 3-quinolinecarboxylic acid antibacterial agents: synthesis and structure-activity relationships. , 1984, Journal of medicinal chemistry.

[24]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[25]  L. M. Atkins,et al.  Antileukemic properties of organoplatinum complexes. , 1976, Journal of the National Cancer Institute.

[26]  T. A. Connors,et al.  New platinum complexes with anti-tumour activity. , 1972, Chemico-biological interactions.

[27]  J. Haveman,et al.  Clonogenic assay of cells in vitro , 2006, Nature Protocols.

[28]  W. Voelter,et al.  Synthesis of new 2‐ferrocenyl‐5‐fluoro‐6‐(4‐substituted‐1‐piperazinyl)‐1H‐benzimidazoles of potential biological interest , 2005 .